ADELAIDE, Australia, May 25, 2021 /PRNewswire/ — IVF Life Group, a number one group of IVF clinics throughout Spain, UK, and Germany, shall be among the many first in Europe to make use of Artificial Intelligence (AI) to non-invasively assess embryos to find out their genetic integrity. The AI product Life Whisperer, developed by international healthcare firm Presagen, makes use of photos of embryos to evaluate their high quality to help with embryo choice, and finally enhance IVF outcomes for sufferers.
Currently, PGT-A genetic testing is likely one of the most used methods that requires cautious removing of three to 5 cells from an embryo to analyse its genetic integrity. As the process remains to be not out there in some nations, and is sort of invasive, Life Whisperer and its AI expertise also can help with this evaluation.
Life Whisperer Genetics, which this month obtained CE Mark in Europe, requires solely normal digital camera photos of embryos to evaluate their genetic integrity. In a US research simulating 91,500 particular person affected person embryo cohorts, Life Whisperer Genetics ranked the genetically regular (euploid) embryo high in 82% of the affected person cohorts. Furthermore, in 96% of the cohorts Life Whisperer Genetics ranked the at the least one genetically regular embryo within the high two embryos.
Presagen’s first product Life Whisperer Viability assesses the identical photos of embryos to find out their probability of resulting in a being pregnant, and is already in use in IVF clinics globally.
Founder & President of IVF Life Group, Dr. Jon Aizpurua stated “For the next two months, IVF Life will offer all patients, at no additional cost, the use of both Life Whisperer Genetics and Life Whisperer Viability. Although patients may still elect to use PGT-A testing, Life Whisperer offers an important pre-screen to help us select the best embryos for further genetic testing, transfer, or freezing.”
Presagen CEO, Dr Michelle Perugini stated “We are excited to be working with IVF Life to enable patients across Europe to access the latest AI technology to help improve their chances of a healthy pregnancy, whilst reducing treatment costs.”
Life Whisperer is already authorised on the market within the UK, Canada, Australia, Japan, India, Thailand, New Zealand, Hong Kong, Singapore and Malaysia.